Ładuje się......

Absence of Cochleotoxicity Measured by Standard and High-Frequency Pure Tone Audiometry in a Trial of Once- versus Three-Times-Daily Tobramycin in Cystic Fibrosis Patients

We undertook assessment of hearing in patients with cystic fibrosis who were taking part in a large randomized controlled trial of once- versus three-times-daily tobramycin for pulmonary exacerbations of cystic fibrosis (the TOPIC study). All patients were eligible to have standard pure tone audiome...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Mulheran, Michael, Hyman-Taylor, Pauline, Tan, Kelvin H.-V., Lewis, Sarah, Stableforth, David, Knox, Alan, Smyth, Alan
Format: Artigo
Język:Inglês
Wydane: American Society for Microbiology 2006
Hasła przedmiotowe:
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1489781/
https://ncbi.nlm.nih.gov/pubmed/16801404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00995-05
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!